Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL073518)
Article History
Received: 28 August 2020
Accepted: 5 April 2021
First Online: 19 April 2021
Compliance with ethical standards
:
: Jonas A. Pologe is a founder and owner of Kestrel Labs, the company that developed NiCO™. Donald H. Arnold is on the medical advisory board for Kestrel Labs. There is no financial compensation for this position. Theodore P. Delianides is a founder and owner of Kestrel Labs, the company that developed NiCO™.
: The data collection methods utilized human blood that was procured from an American Association of Blood Banks (AABB) accredited blood bank (Vitalant, formerly Blood Systems Inc.), which provides de-identified samples. The proposed work was exempt from requiring Institutional Review Board approval per peer review by the assigned Scientific Review Group of the National Heart Lung and Blood Institute.